Latest News

The American drug regulator, the Food and Drug Administration (FDA), stated in a report yesterday that it may consider mandatory cardiovascular risk studies before considering any weight loss medication for approval, even if there is no evidence to suggest that there is any cardiovascular risk assoc...

The Food and Drug Administration (FDA) in the US has given the all clear for phase I trials of Antipotide(a potential new anti-obesity drug), having approved Arrowhead Research Corporation’s Investigational New Drug Application...

Topiramate has been proven to be a successful weight loss drug for those who can tolerate the side effects that go with it according to the results of a meta-analysis of previously published studies which will be presented at The Endocrine Society’s 93rd Annual Meeting in Boston...

Following the results of meta-analyses of phase III drug trials, Arena presented its findings at the European Congress on Obesity and has demonstrated that Lorcaserin, its weight loss drug candidate, can help the obese shed up to one third of their original body weight...

The MHRA (Medicines and Healthcare products Regulatory Agency) will be issuing a new herbal regulation at the end of the month...